U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07376486) titled 'Duodenal ReCET as an Early Treatment for Type 2 DM' on Jan. 22.
Brief Summary: This study is designed to evaluate the efficacy and safety of endoscopic duodenal re-cellularization therapy in individuals with in patients with a recent diagnosis of type 2 diabetes mellitus (T2DM).
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Diabete Mellitus
T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
Intervention:
PROCEDURE: ReCET treatment
The ReCET procedure utilizes the ReCET catheter to deliver non-thermal pulsed electric field to the duodenum to induce cell regeneration. The catheter is introduced to the...